Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
NCT02808104
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG:
mazindol
Sponsor
NLS Pharmaceutics